Health Canada inspection
Bristol-Myers Squibb Manufacturing Company Unlimited Company: Health Canada inspection of May 11, 2023
Health Canada · GMP · rating C
Key facts
| Establishment | Bristol-Myers Squibb Manufacturing Company Unlimited Company |
|---|---|
| City | Humacao |
| Province | PR |
| Country | United States |
| Program | GMP |
| Start date | May 9, 2023 |
| End date | May 11, 2023 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.